viewSareum Holdings PLC

Sareum Holdings says it is close to winning US patent protection for cancer immunotherapy programme

Subject to certain formalities, the company expects the patent will be granted within the next three months

Sareum Holdings PLC -

Sareum Holdings PLC (LON:SAR) said the US Patent and Trademark Office has issued what is called a notice of allowance offering protection for its pre-clinical cancer immunotherapy drug candidate.

The patent will protect the SDC-1802 molecule and its pharmaceutical preparation.

SDC-1802 is a dual tyrosine kinase 2 (TYK2)/Janus kinase 1 (JAK1) inhibitor. TYK2 and JAK1 are members of the Janus Kinase (JAK) family of protein kinase enzymes that play roles in autoimmune diseases and tumour cell proliferation in cancer.

In  statement, Dr John Reader, Sareum's chief scientific officer, said: "The granting of this patent in the US will complete the protection of the intellectual property for our proprietary SDC-1802 programme across all major markets.

“The board believes that the patent will enhance the value of its TYK2/JAK1 inhibitor programmes and the company's negotiating position as it continues to engage in discussions with potential licence partners."

Quick facts: Sareum Holdings PLC

Price: 2.35 GBX

Market: AIM
Market Cap: £76.79 m

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events


The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Sareum Holdings PLC named herein, including the promotion by the Company of Sareum Holdings PLC in any Content on the Site, the Company...


Market Report: Washington riots and Trump Twitter suspension drag down FTSE...

The Market Report with Katie Pilbeam. FTSE 100 has lost a little momentum this morning after reaching its highest level since early March on Wednesday.  Facebook and Twitter have blocked Donald Trump from their platforms after supporters swarmed the Capitol building on Wednesday. The US...

1 week, 3 days ago

2 min read